Alector (ALEC) Debt Ratio (2024 - 2026)

Alector's (ALEC) quarterly Debt Ratio came in at 0.04 in Q1 2026, up 75.63% year-on-year from 0.02 in Q1 2025, and up 23.21% on a QoQ basis from 0.03 in Q4 2025.

Alector (ALEC) Debt Ratio (2024 - 2026) Analysis & Trends

Alector (ALEC) has 3 years of Debt Ratio data on file, last reported at 0.04 in Q1 2026.

  • On a quarterly basis, Debt Ratio rose 75.63% year-over-year to 0.04 in Q1 2026; TTM through Mar 2026 was 0.04, a 75.63% increase from a year earlier, with the FY2025 full-year figure at 0.03, up 64.8% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.04, up from 0.03 in the prior quarter.
  • Over the last five years, Debt Ratio for ALEC reached as high as 0.04 in Q1 2026 and fell as low as 0.02 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.03 across 3 years, with a median of 0.03 in 2025.
  • Across the five-year window, Debt Ratio surged 64.8% in 2025 and jumped 75.63% in 2026, its largest moves.
  • Year by year, Debt Ratio stood at 0.02 in 2024, then soared by 64.8% to 0.03 in 2025, then climbed by 23.21% to 0.04 in 2026.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.04 in Q1 2026, 0.03 in Q4 2025, and 0.03 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alector 164.78 Mn -41.74 Mn - 0.04

Historic Data

Download Data
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 0.03
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.02
Dec 31, 2024 0.02